Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Overexpression of keratin 17 is associated with poor prognosis in epithelial ovarian cancer.

Wang YF, Lang HY, Yuan J, Wang J, Wang R, Zhang XH, Zhang J, Zhao T, Li YR, Liu JY, Zeng LH, Guo GZ.

Tumour Biol. 2013 Jun;34(3):1685-9. doi: 10.1007/s13277-013-0703-5. Epub 2013 Feb 21.

PMID:
23430585
2.

Clinical significance of galectin-7 in epithelial ovarian cancer.

Kim HJ, Jeon HK, Lee JK, Sung CO, Do IG, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.

Anticancer Res. 2013 Apr;33(4):1555-61.

PMID:
23564797
3.

Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.

Huang LP, Yu YH, Sheng C, Wang SH.

Int J Gynecol Cancer. 2012 Sep;22(7):1170-6. doi: 10.1097/IGC.0b013e318261d89c.

PMID:
22810971
4.

Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.

Zhang J, Tang L, Chen Y, Duan Z, Xiao L, Li W, Liu X, Shen L.

Hum Pathol. 2015 Sep;46(9):1331-40. doi: 10.1016/j.humpath.2015.05.015. Epub 2015 May 30.

PMID:
26193797
5.

CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer.

Liu P, Sun YL, Du J, Hou XS, Meng H.

Int J Gynecol Cancer. 2012 May;22(4):586-92. doi: 10.1097/IGC.0b013e31823c36b8.

PMID:
22266931
6.

[Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].

Zhang MZ, Qiao YH, Suo ZH.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):848-52. Chinese.

PMID:
19173831
7.

Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.

Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, Tognon G, Odicino FE, Facchetti F, Pecorelli S, Santin AD.

Eur J Cancer. 2010 Mar;46(5):944-53. doi: 10.1016/j.ejca.2009.12.019. Epub 2010 Jan 8.

PMID:
20060709
8.

ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.

Ni SS, Zhang J, Zhao WL, Dong XC, Wang JL.

Tumour Biol. 2013 Jun;34(3):1813-8. doi: 10.1007/s13277-013-0721-3. Epub 2013 Mar 9.

PMID:
23475633
9.

Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.

Shigemasa K, Tian X, Gu L, Tanimoto H, Underwood LJ, O'Brien TJ, Ohama K.

Oncol Rep. 2004 Jun;11(6):1153-9.

PMID:
15138549
10.

Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.

Motamed-Khorasani A, Jurisica I, Letarte M, Shaw PA, Parkes RK, Zhang X, Evangelou A, Rosen B, Murphy KJ, Brown TJ.

Oncogene. 2007 Jan 11;26(2):198-214. Epub 2006 Jul 10.

PMID:
16832351
11.

Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.

Jung SG, Kwon YD, Song JA, Back MJ, Lee SY, Lee C, Hwang YY, An HJ.

Cancer Sci. 2010 Sep;101(9):1977-83. doi: 10.1111/j.1349-7006.2010.01641.x.

12.

Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer.

Guo F, Feng L, Hu JL, Wang ML, Luo P, Zhong XM, Deng AM.

Tumour Biol. 2015 Jan;36(1):453-8. doi: 10.1007/s13277-014-2662-x. Epub 2014 Oct 1.

PMID:
25270739
13.

Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma.

Ide M, Kato T, Ogata K, Mochiki E, Kuwano H, Oyama T.

Ann Surg Oncol. 2012 Oct;19(11):3506-14. doi: 10.1245/s10434-012-2437-9. Epub 2012 Jun 14.

PMID:
22695933
14.
15.

Clinical significance of annexin II expression in human non-small cell lung cancer.

Jia JW, Li KL, Wu JX, Guo SL.

Tumour Biol. 2013 Jun;34(3):1767-71. doi: 10.1007/s13277-013-0715-1. Epub 2013 Mar 14.

PMID:
23494179
16.

Activated matrix metalloproteinase-2--a potential marker of prognosis for epithelial ovarian cancer.

Wu X, Li H, Kang L, Li L, Wang W, Shan B.

Gynecol Oncol. 2002 Jan;84(1):126-34.

PMID:
11748988
17.

Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.

Choi YL, Kim J, Kwon MJ, Choi JS, Kim TJ, Bae DS, Koh SS, In YH, Park YW, Kim SH, Ahn G, Shin YK.

Histol Histopathol. 2007 Nov;22(11):1185-95.

PMID:
17647191
18.

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.

Peng DX, Luo M, Qiu LW, He YL, Wang XF.

Oncol Rep. 2012 Apr;27(4):1238-44. doi: 10.3892/or.2012.1625. Epub 2012 Jan 11.

19.

Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.

Fridley BL, Jenkins GD, Tsai YY, Song H, Bolton KL, Fenstermacher D, Tyrer J, Ramus SJ, Cunningham JM, Vierkant RA, Chen Z, Chen YA, Iversen E, Menon U, Gentry-Maharaj A, Schildkraut J, Sutphen R, Gayther SA, Hartmann LC, Pharoah PD, Sellers TA, Goode EL.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):529-36. doi: 10.1158/1055-9965.EPI-11-0741. Epub 2012 Feb 2.

20.

Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.

Deng B, Zhao Y, Gou W, Chen S, Mao X, Takano Y, Zheng H.

Tumour Biol. 2013 Oct;34(5):2617-24. doi: 10.1007/s13277-013-0811-2. Epub 2013 May 9.

Items per page

Supplemental Content

Write to the Help Desk